Get alerts on this situation

We’ll email you as it develops, and you can follow the whole thread from day one.

Unsubscribe anytime.

[SITUATION] · [ACTIVE]

2 clusters · 8 sources · 8 days · First seen 11 days ago · Last updated 4 days ago

Egypt health sector infrastructure upgrades

Entities: Acdima Group · Khaled Abdel Gafar · Dr. Khalid Abdelghaffar · Arab Group for Pharmaceutical Industries and Medical Supplies (Akdima) · 10th of Ramadan City

Overview

Following mid‑July inspections of schools, farms and hospitals, the health‑sector push continued on 26 July 2026 when Health Minister Dr Khalid Abdel‑Ghaffar inaugurated the EIPICO 3 biopharmaceutical plant in the 10th of Ramadan industrial city. The $100 million, 10 500 m² modular facility, owned by the Arab Group for Pharmaceutical Industries and Medical Supplies (Akdima), is the first of its kind in Egypt and the Middle East. It will produce 14 biologic medicines for cancer, blood disorders, fertility, kidney disease and anaemia using Swedish‑supplied bioreactors and automated packaging. EIPICO, which already operates three sites totaling 130 500 m² and exports to more than 60 countries, expects the new plant to strengthen domestic drug supply, lower patient costs and expand Egypt’s pharmaceutical export footprint.

Claims

What the coverage asserts, and how well corroborated each claim is across sources.

[● 4 SOURCES] The Egyptian Minister of Health and Population inaugurated the EIPICO 3 factory in the city of 10th of Ramadan. (6ded41b8, 694ff12b, 34da785a, 52d6fcda)
[● 4 SOURCES] The factory is owned by the Arab Group for Pharmaceutical Industries and Medical Supplies (Akdima). (6ded41b8, 694ff12b, 34da785a, 52d6fcda)
[● 4 SOURCES] Investment in the plant exceeds $100 million and the facility covers 10 500 m². (6ded41b8, 694ff12b, 34da785a, 52d6fcda)
[● 4 SOURCES] The plant is the first modular‑construction biopharma facility in Egypt and the Middle East that produces biologics from genetically modified cells to final products. (6ded41b8, 694ff12b, 34da785a, 52d6fcda)
[● 4 SOURCES] The factory will produce 14 biopharmaceutical products for cancer, blood diseases, fertility, kidney disease and anaemia. (6ded41b8, 694ff12b, 34da785a, 52d6fcda)
[● 4 SOURCES] Production lines include bioreactors, preparation zones and automated packaging lines using modular construction technology in cooperation with Swedish firm Pharmadule. (6ded41b8, 694ff12b, 34da785a, 52d6fcda)
[● 4 SOURCES] EIPICO operates three factories totaling 130 500 m², 59 production lines, producing 425 pharmaceutical products with an annual output of 327 million units. (6ded41b8, 694ff12b, 34da785a, 52d6fcda)
[● 4 SOURCES] In the previous year the company's production value was 10.8 billion Egyptian pounds, sales 9.3 billion, exporting to over 60 countries with $60 million in exports, representing 25 % of Egypt’s drug出口 (6ded41b8, 694ff12b, 34da785a, 52d6fcda)

Timeline

4 days ago

[BUSINESS] 8 sources
Egypt launches EIPICO 3 biopharma plant in 10th of Ramadan
Egypt’s Health Minister inaugurated the $100 million EIPICO 3 biopharma plant in 10th of Ramadan, the region’s first modular facility that will produce 14 biologic drugs, boosting local supply and exports.
11 days ago

[POLITICS] 2 sources
Egypt's Menofia Governor Inspects School Renovation and Meets Student Advocate
Menofia governor inspected a 18 million‑pound school renovation and pledged aid to student Neda Mohamed, including equipment, furniture, and debt relief.

Sources

alahalygate.com · almessa.gomhuriaonline.com · alnaharegypt.com · anbaaalyoumeg.com · elaosboa.com · elbalad.news · elzmannews.com · vetogate.com

This summary has been updated 2 times: see revision history